These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30352046)

  • 1. Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain.
    Jo S; Fonseca TL; Bocco BMLC; Fernandes GW; McAninch EA; Bolin AP; Da Conceição RR; Werneck-de-Castro JP; Ignacio DL; Egri P; Németh D; Fekete C; Bernardi MM; Leitch VD; Mannan NS; Curry KF; Butterfield NC; Bassett JHD; Williams GR; Gereben B; Ribeiro MO; Bianco AC
    J Clin Invest; 2019 Jan; 129(1):230-245. PubMed ID: 30352046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological relevance of deiodinase polymorphism.
    Bianco AC; Kim BS
    Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):341-346. PubMed ID: 30063552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients.
    Castagna MG; Dentice M; Cantara S; Ambrosio R; Maino F; Porcelli T; Marzocchi C; Garbi C; Pacini F; Salvatore D
    J Clin Endocrinol Metab; 2017 May; 102(5):1623-1630. PubMed ID: 28324063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No Effect of the Thr92Ala Polymorphism of Deiodinase-2 on Thyroid Hormone Parameters, Health-Related Quality of Life, and Cognitive Functioning in a Large Population-Based Cohort Study.
    Wouters HJ; van Loon HC; van der Klauw MM; Elderson MF; Slagter SN; Kobold AM; Kema IP; Links TP; van Vliet-Ostaptchouk JV; Wolffenbuttel BH
    Thyroid; 2017 Feb; 27(2):147-155. PubMed ID: 27786042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone.
    Luongo C; De Stefano MA; Ambrosio R; Volpe F; Porcelli T; Golia V; Bellevicine C; Troncone G; Masone S; Damiano V; Matano E; Klain M; Schlumberger M; Salvatore D
    Thyroid; 2023 Mar; 33(3):294-300. PubMed ID: 36680751
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of Resistance to Exogenous Thyroxine in Humans.
    Lacámara N; Lecumberri B; Barquiel B; Escribano A; González-Casado I; Álvarez-Escolá C; Aleixandre-Blanquer F; Morales F; Alfayate R; Bernal-Soriano MC; Miralles R; Yildirim Simsir I; Özgen AG; Bernal J; Berbel P; Moreno JC
    Thyroid; 2020 Dec; 30(12):1732-1744. PubMed ID: 32498666
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalent polymorphism in thyroid hormone-activating enzyme leaves a genetic fingerprint that underlies associated clinical syndromes.
    McAninch EA; Jo S; Preite NZ; Farkas E; Mohácsik P; Fekete C; Egri P; Gereben B; Li Y; Deng Y; Patti ME; Zevenbergen C; Peeters RP; Mash DC; Bianco AC
    J Clin Endocrinol Metab; 2015 Mar; 100(3):920-33. PubMed ID: 25569702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liothyronine use in primary hypothyroidism - current concepts.
    Concepción-Zavaleta MJ; Ildefonso-Najarro SP; Paz-Ibarra JL; Valdivia Fernández-Dávila FR; Deutz Gómez-Condori DC; Rivera-Fabián KE; Herrera-Cabezas RG; Concepción-Urteaga LA
    Endokrynol Pol; 2021; 72(6):650-660. PubMed ID: 34855197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of DIO2 and MCT10 Polymorphisms With Persistent Symptoms in LT4-Treated Patients in the UK Biobank.
    Jensen CZ; Isaksen JL; Ahlberg G; Olesen MS; Nygaard B; Ellervik C; Kanters JK
    J Clin Endocrinol Metab; 2024 Jan; 109(2):e613-e622. PubMed ID: 37740545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine+Liothyronine in Hypothyroidism.
    Shakir MKM; Brooks DI; McAninch EA; Fonseca TL; Mai VQ; Bianco AC; Hoang TD
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4400-e4413. PubMed ID: 34185829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine.
    Werneck de Castro JP; Fonseca TL; Ueta CB; McAninch EA; Abdalla S; Wittmann G; Lechan RM; Gereben B; Bianco AC
    J Clin Invest; 2015 Feb; 125(2):769-81. PubMed ID: 25555216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scope and limitations of iodothyronine deiodinases in hypothyroidism.
    Gereben B; McAninch EA; Ribeiro MO; Bianco AC
    Nat Rev Endocrinol; 2015 Nov; 11(11):642-652. PubMed ID: 26416219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does combination T4 and T3 therapy make sense?
    McDermott MT
    Endocr Pract; 2012; 18(5):750-7. PubMed ID: 22548953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Gene Expression in Systemic Hypothyroidism and Mouse Models of MCT8 Deficiency: The Mct8-Oatp1c1-Dio2 Triad.
    Morte B; Gil-Ibañez P; Heuer H; Bernal J
    Thyroid; 2021 Jun; 31(6):985-993. PubMed ID: 33307956
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4.
    Schneider MJ; Fiering SN; Pallud SE; Parlow AF; St Germain DL; Galton VA
    Mol Endocrinol; 2001 Dec; 15(12):2137-48. PubMed ID: 11731615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis.
    Heemstra KA; Hoftijzer HC; van der Deure WM; Peeters RP; Fliers E; Appelhof BC; Wiersinga WM; Corssmit EP; Visser TJ; Smit JW
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):279-83. PubMed ID: 19018782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levothyroxine Monotherapy: What Works Better for the Individual With Hypothyroidism?
    Hennessey JV
    Endocr Pract; 2023 Jul; 29(7):572-580. PubMed ID: 37419564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the common DIO2 Thr92Ala polymorphism and metabolic phenotypes in 7342 Danish white subjects.
    Grarup N; Andersen MK; Andreasen CH; Albrechtsen A; Borch-Johnsen K; Jørgensen T; Auwerx J; Schmitz O; Hansen T; Pedersen O
    J Clin Endocrinol Metab; 2007 Jan; 92(1):363-6. PubMed ID: 17077128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current evidence for the treatment of hypothyroidism with levothyroxine/levotriiodothyronine combination therapy versus levothyroxine monotherapy.
    Hennessey JV; Espaillat R
    Int J Clin Pract; 2018 Feb; 72(2):. PubMed ID: 29381251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ala92 type 2 deiodinase allele increases risk for the development of hypertension.
    Gumieniak O; Perlstein TS; Williams JS; Hopkins PN; Brown NJ; Raby BA; Williams GH
    Hypertension; 2007 Mar; 49(3):461-6. PubMed ID: 17224473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.